LMU spin-off that amplifies the sensitivity of lateral flow tests up to 100x with DNA origami nanostructures.
| Date | Round | Amount |
|---|---|---|
| Dec 2025 | Seed Munich-based Amplifold closed an oversubscribed €5 million seed co-led by Matterwave Ventures and XISTA Science Ventures for ultrasensitive diagnostics with DNA origami. | $5.8M |
Tap an investor to see what else they have backed.
Data is community-curated and may be incomplete.